Indigenous Traditions
The living indigenous traditions from which most psychedelic medicines derive - the diversity of these traditions, what they understand about the medicines, and the ethical questions their appropriation raises.
Indigenous traditions are the original ceremonial and medicinal contexts in which psychedelic plants and fungi have been used — many for thousands of years — by Indigenous peoples across the Americas, Africa, and Asia. Major lineages include ayahuasca use among Amazonian peoples (Shipibo, Asháninka, Shuar, and dozens of others), peyote ceremony in the Native American Church and among the Wixáritari (Huichol), psilocybin mushroom rituals among the Mazatec of Oaxaca (notably María Sabina), iboga initiation in Bwiti tradition of Gabon, and San Pedro (Huachuma) use across the Andes. The modern Western movement of these medicines into clinics, retreats, and pharmaceutical pipelines raises questions about reciprocity, intellectual property, and ecological sustainability.
Indigenous traditions form the historical and living foundation from which the modern understanding of psychedelic medicines has largely derived. Most of the substances now studied in clinical trials - psilocybin, mescaline, DMT, ibogaine - have been used within specific indigenous traditions for documented centuries, and in many cases for far longer. Understanding these traditions is not merely an historical exercise; it is relevant to how the medicines are understood, how they are used, and who benefits from their growing presence in mainstream culture.
The word "indigenous" covers an enormous range of distinct peoples, traditions, and cosmologies. Ayahuasca practices vary significantly between the Shipibo-Conibo, the Shuar, the Ashaninka, and the dozens of other Amazonian peoples who have developed specific relationships with the vine. Peyote ceremonies among the Native American Church are distinct from traditional Huichol practices in Mexico. Psilocybin mushroom ceremonies in the Oaxacan Mazatec tradition, documented in part through the work of ethnomycologist R. Gordon Wasson (whose access to the ceremonies became itself a source of controversy), are distinct from highland Maya uses.
What these traditions share is a cosmological framework in which the substances are understood as entities or teachers rather than as pharmacological tools - and in which the healer's role involves navigating a relational space, not simply administering a compound. Healing is understood as involving the restoration of right relationship: between the person and their community, their ancestry, their spiritual environment. These frameworks are not easily translated into the individualistic, psychopathology-focused frameworks of Western psychiatry, and much that matters in them does not survive translation.
The relationship between the current psychedelic renaissance and indigenous traditions is ethically charged in ways the field continues to grapple with. Patent applications on indigenous plant preparation methods, retreat industries that commercialize sacred ceremonies without adequate benefit-sharing, and the systematic exclusion of indigenous knowledge holders from the academic and clinical conversations that have been built on their knowledge are all live concerns - not historical ones.